Lv630
2410 积分 2024-08-14 加入
Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective study
14天前
已完结
A Review of Recent Advances in the Molecular Mechanisms Underlying Brain Metastasis in Lung Cancer
1个月前
已完结
Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options
2个月前
已完结
Recent advances in tropomysosin receptor kinase (TRK) inhibitors: a 2023–2024 patent landscape review
3个月前
已完结
HER2-targeted therapies beyond breast cancer — an update
3个月前
已完结
Protein Kinases – High Yield Targets for Cancer and Dementia Drug Discovery
4个月前
已完结
Routine molecular profiling of patients with NSCLC
4个月前
已完结
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program
4个月前
已关闭
Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer
4个月前
已完结
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial
4个月前
已完结
皖公网安备34019202002308
